BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 15, 2026
Home
»
Topics
»
Infection
» HIV/AIDS
HIV/AIDS
RSS
Gilead initiates phase III program for tenofovir alafenamide in HIV
Jan. 25, 2013
European approval for new 800-mg tablet of Prezista
Jan. 16, 2013
GeoVax completes enrollment in phase I/II trial for HIV/AIDS vaccine
Jan. 14, 2013
Tobira Therapeutics reports data from phase IIb cenicriviroc trial
Jan. 10, 2013
Takara Bio begins phase I trial of HIV-1 gene therapy
Jan. 10, 2013
Clinical evaluation of the safety and tolerability of HIV vaccine alternative
Jan. 8, 2013
Novel HIV vaccine adjuvants created by French investigators
Jan. 7, 2013
ViiV Healthcare files for approval of dolutegravir
Dec. 19, 2012
Biotron's BIT-225 completes proof-of-concept trial in HIV
Dec. 17, 2012
Regulatory approvals received for new study of Vacc-4x
Dec. 7, 2012
Previous
1
2
…
84
85
86
87
88
89
90
91
92
…
424
425
Next
RSS